Schorno Dean L 4
4 · RIGEL PHARMACEUTICALS INC · Filed Feb 6, 2024
Insider Transaction Report
Form 4
Schorno Dean L
EVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2024-02-05$1.14/sh−7,027$8,011→ 402,891 total - Sale
Common Stock
2024-02-02$1.13/sh−5,601$6,327→ 409,918 total
Footnotes (2)
- [F1]These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $1.1228 to $1.13. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission staff, full information regarding the shares sold at each such separate price.